Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Egalet Corp (EGLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,245
  • Shares Outstanding, K 56,770
  • Annual Sales, $ 26,140 K
  • Annual Income, $ -69,360 K
  • 36-Month Beta 0.67
  • Price/Sales 0.26
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.16
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +54.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0750 +46.67%
on 09/20/18
0.3700 -70.27%
on 09/18/18
-0.2400 (-68.57%)
since 09/14/18
3-Month
0.0750 +46.67%
on 09/20/18
0.6800 -83.82%
on 08/07/18
-0.2750 (-71.43%)
since 07/16/18
52-Week
0.0750 +46.67%
on 09/20/18
1.5700 -92.99%
on 11/16/17
-0.9300 (-89.42%)
since 10/16/17

Most Recent Stories

More News
Egalet Reports Second Quarter 2018 Financial Results

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.1100 (unch)
Market Trends Toward New Normal in Egalet, PPG Industries, Synergy Pharmaceuticals, Equity Residential, Array BioPharma, and Holly Energy Partners -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Egalet Corporation (NASDAQ:EGLT),...

HEP : 31.46 (+4.28%)
PPG : 97.96 (+1.88%)
ARRY : 15.15 (+10.10%)
EQR : 64.34 (+2.16%)
EGLT : 0.1100 (unch)
SGYP : 1.44 (+4.35%)
Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018

WAYNE, Penn. , July 25, 2018 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative...

EGLT : 0.1100 (unch)
Egalet Reports First Quarter 2018 Financial Results

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.1100 (unch)
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.1100 (unch)
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER

WAYNE, Pa. , May 7, 2018 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative...

EGLT : 0.1100 (unch)
Egalet to Present at the 3rd Annual Disruptive Growth & Healthcare Conference

WAYNE, PA / ACCESSWIRE / May 2, 2018 / Egalet Corporation (NASDAQ: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments...

EGLT : 0.1100 (unch)
Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions,...

EGLT : 0.1100 (unch)
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.1100 (unch)
Factors of Influence in 2018, Key Indicators and Opportunity within Clifton, CSG Systems International, ArcelorMittal, Denny's, Yamana Gold, and Egalet -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clifton Bancorp Inc. (NASDAQ:CSBK),...

CSGS : 36.76 (+1.72%)
AUY : 2.62 (-2.24%)
CSBK : 15.65 (+0.45%)
MT : 28.50 (+1.17%)
EGLT : 0.1100 (unch)
DENN : 14.51 (+0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade EGLT with:

Key Turning Points

2nd Resistance Point 0.1447
1st Resistance Point 0.1273
Last Price 0.1100
1st Support Level 0.0973
2nd Support Level 0.0847

See More

52-Week High 1.5700
Fibonacci 61.8% 0.9989
Fibonacci 50% 0.8225
Fibonacci 38.2% 0.6461
Last Price 0.1100
52-Week Low 0.0750

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar